On-Q-ity develops non-invasive diagnostic monitoring tools for use in the treatment of individual cancer patients.
Description
On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. There platform will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival.
Products currently in development are based on two core technologies: 1) DNA repair biomarkers that predict treatment response and 2) Microfluidic chip technology that enables capture, enumeration and characterization of circulating tumor cells (CTCs) in the bloodstream.
Last funding
Noway Youcantaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Waltham, Massachusetts, United States, North America